Middle East and Africa Point-of-Care Molecular Diagnostics Market
The Middle East and Africa Point-of-Care Molecular Diagnostics Market size was valued at US$ 94.0 Mn in 2021 and is projected to reach US$ 212.9 Mn by 2028, growing at a CAGR of 12.4% during 2021 - 2028.
Report Coverage
- Product & Services: Assays and Kits, Instruments, Services and Software
- Technology: PCR, Isothermal Nucleic Acid Amplification Technology, Other Technologies
- Application: Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, Other Applications
- End User: Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes
US$ 94.0 Mn
Market size in 2021
US$ 212.9 Mn
Market Size by 2028
12.4%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East and Africa Point-of-Care Molecular Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East and Africa Point-of-Care Molecular Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East and Africa Point-of-Care Molecular Diagnostics Market Regional Analysis
6.2 Middle East and Africa Point-of-Care Molecular Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Middle East and Africa Point-of-Care Molecular Diagnostics Market Forecast Analysis
7. Middle East and Africa Point-of-Care Molecular Diagnostics Market Analysis – by Product & Services
7.1 Assays and Kits
- 7.1.1 Overview
- 7.1.2 Assays and Kits: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Services and Software
- 7.3.1 Overview
- 7.3.2 Services and Software: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Middle East and Africa Point-of-Care Molecular Diagnostics Market Analysis – by Technology
8.1 PCR
- 8.1.1 Overview
- 8.1.2 PCR: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Isothermal Nucleic Acid Amplification Technology
- 8.2.1 Overview
- 8.2.2 Isothermal Nucleic Acid Amplification Technology: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Other Technologies
- 8.3.1 Overview
- 8.3.2 Other Technologies: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Middle East and Africa Point-of-Care Molecular Diagnostics Market Analysis – by Application
9.1 Infectious Diseases
- 9.1.1 Overview
- 9.1.2 Infectious Diseases: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Oncology
- 9.2.1 Overview
- 9.2.2 Oncology: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Hematology
- 9.3.1 Overview
- 9.3.2 Hematology: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Prenatal Testing
- 9.4.1 Overview
- 9.4.2 Prenatal Testing: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.5 Endocrinology
- 9.5.1 Overview
- 9.5.2 Endocrinology: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.6 Other Applications
- 9.6.1 Overview
- 9.6.2 Other Applications: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Middle East and Africa Point-of-Care Molecular Diagnostics Market Analysis – by End User
10.1 Hospitals and Clinics
- 10.1.1 Overview
- 10.1.2 Hospitals and Clinics: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Diagnostic Laboratories
- 10.2.1 Overview
- 10.2.2 Diagnostic Laboratories: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.3 Research and Academic Institutes
- 10.3.1 Overview
- 10.3.2 Research and Academic Institutes: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
11. Middle East and Africa Point-of-Care Molecular Diagnostics Market – Middle East and Africa Analysis
11.1 Overview
11.2 Middle East and Africa- 11.2.1 Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
- 11.2.1.1 Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 South Africa: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 South Africa: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
- 11.2.1.1.2 South Africa: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
- 11.2.1.1.3 South Africa: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by Application
- 11.2.1.1.4 South Africa: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by End User
- 11.2.1.2 Saudi Arabia: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Saudi Arabia: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
- 11.2.1.2.2 Saudi Arabia: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
- 11.2.1.2.3 Saudi Arabia: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by Application
- 11.2.1.2.4 Saudi Arabia: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by End User
- 11.2.1.3 UAE: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 UAE: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
- 11.2.1.3.2 UAE: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
- 11.2.1.3.3 UAE: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by Application
- 11.2.1.3.4 UAE: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by End User
- 11.2.1.4 Rest of Middle East and Africa: Middle East and Africa Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
- 11.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
- 11.2.1.4.3 Rest of Middle East and Africa: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by Application
- 11.2.1.4.4 Rest of Middle East and Africa: Middle East and Africa Point-of-Care Molecular Diagnostics Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 bioMérieux SA
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 F. Hoffmann-La Roche Ltd.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Danaher Corporation
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Enzo Biochem, Inc.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Abbott
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Meridian BioScience, Inc.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Biocartis
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Quidel Corporation
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Bio-Rad Laboratories, Inc.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full M Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
